Journal of Clinical Endocrinology & Metabolism, Vol 81, 2179-2185, Copyright © 1996 by Endocrine Society

ARTICLES

Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system

A Campos-Barros, T Hoell, A Musa, S Sampaolo, G Stoltenburg, G Pinna, M Eravci, H Meinhold and A Baumgartner
Department of Nuclear Medicine, Benjamin Franklin Hospital, Free University of Berlin, Germany.

In the present study we investigated the biochemical properties of in vitro phenolic (5'D) and tyrosyl (5D) ring deiodination and the tissue concentrations of T4, T3, and rT3 in adult human central nervous system (CNS) tissue. All samples were obtained from nontumoral tissue at autopsy (n = 6) or neurosurgical operation (n = 5). Both phenolic and tyrosyl ring deiodinase activities were demonstrable in all samples obtained intraoperatively, whereas only tyrosyl ring deiodination was evident in the tissues obtained postmortem. The phenolic ring deiodination pathway corresponded to the type II 5'-deiodinase isoenzyme with regard to its high affinity for T4 and rT3 (Km = 2.2 and 2.4 nmol/L, respectively), its insensitivity to 6-propyl-n-2-thiouracil (PTU), and the sequential reaction mechanism. No PTU-sensitive 5'- deiodination of rT3 was demonstrable. Tyrosyl ring deiodination of both T4 and T3 showed typical type III 5D kinetics (Ka, 6.5 nmol/L for T4 and 3.4 nmol/L for T3) and was PTU insensitive. Nanomolar concentrations of tissue T4, T3, and rT3 were detected in samples obtained both intraoperatively and postmortem. They were very similar to the absolute values of the apparent Km for T4, T3, and rT3 in the phenolic and tyrosyl ring deiodination pathways. In conclusion, we have demonstrated the coexistence of both phenolic and tyrosyl ring deiodinase activities in the human CNS. Their kinetic characteristics, substrate specificity, and reaction mechanisms are very similar to the corresponding type II 5'- and type III 5-iodothyronine deiodinase activities in rat brain. In contrast to the findings in the rat CNS, no PTU-sensitive phenolic ring deiodinase (i.e. type I 5'D) activity was found in the human CNS. This may explain the relatively high tissue concentrations of rT3.

This article has been cited by other articles:

				A. Lamirand, S. Pallud-Mothre, M. Ramauge, M. Pierre, and F. Courtin Oxidative Stress Regulates Type 3 Deiodinase and Type 2 Deiodinase in Cultured Rat Astrocytes Endocrinology, July 1, 2008; 149(7): 3713 - 3721. [Abstract] [Full Text] [PDF]

				M. H. A. Kester, G. G. J. M. Kuiper, R. Versteeg, and T. J. Visser Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines Endocrinology, December 1, 2006; 147(12): 5845 - 5854. [Abstract] [Full Text] [PDF]

				A. Zeold, M. Doleschall, M. C. Haffner, L. P. Capelo, J. Menyhert, Z. Liposits, W. S. da Silva, A. C. Bianco, I. Kacskovics, C. Fekete, et al. Characterization of the Nuclear Factor-{kappa}B Responsiveness of the Human dio2 Gene Endocrinology, September 1, 2006; 147(9): 4419 - 4429. [Abstract] [Full Text] [PDF]

				J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF]

				J. Simpson, F. L. R. Williams, C. Delahunty, H. van Toor, S.-Y. Wu, S. A. Ogston, T. J. Visser, R. Hume, and with collaboration from the Scottish Preterm Thyro Serum Thyroid Hormones in Preterm Infants and Relationships to Indices of Severity of Intercurrent Illness J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1271 - 1279. [Abstract] [Full Text] [PDF]

				S. Sampaolo, A. Campos-Barros, G. Mazziotti, S. Carlomagno, V. Sannino, G. Amato, C. Carella, and G. Di Iorio Increased Cerebrospinal Fluid Levels of 3,3',5'-Triiodothyronine in Patients with Alzheimer's Disease J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 198 - 202. [Abstract] [Full Text] [PDF]

				F. W. J. S. Wassen, W. Klootwijk, E. Kaptein, D. J. Duncker, T. J. Visser, and G. G. J. M. Kuiper Characteristics and Thyroid State-Dependent Regulation of Iodothyronine Deiodinases in Pigs Endocrinology, September 1, 2004; 145(9): 4251 - 4263. [Abstract] [Full Text] [PDF]

				B. Gereben, J. Pachucki, A. Kollar, Z. Liposits, and C. Fekete Ontogenic Redistribution of Type 2 Deiodinase Messenger Ribonucleic Acid in the Brain of Chicken Endocrinology, August 1, 2004; 145(8): 3619 - 3625. [Abstract] [Full Text] [PDF]

				M. H. A. Kester, R. Martinez de Mena, M. Jesus Obregon, D. Marinkovic, A. Howatson, T. J. Visser, R. Hume, and G. Morreale de Escobar Iodothyronine Levels in the Human Developing Brain: Major Regulatory Roles of Iodothyronine Deiodinases in Different Areas J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3117 - 3128. [Abstract] [Full Text] [PDF]

				F. Santini, P. Vitti, L. Chiovato, G. Ceccarini, M. Macchia, L. Montanelli, G. Gatti, V. Rosellini, C. Mammoli, E. Martino, et al. Role for Inner Ring Deiodination Preventing Transcutaneous Passage of Thyroxine J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2825 - 2830. [Abstract] [Full Text] [PDF]

				G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference Endocrinology, June 1, 2003; 144(6): 2505 - 2513. [Abstract] [Full Text] [PDF]

				M. Baqui, D. Botero, B. Gereben, C. Curcio, J. W. Harney, D. Salvatore, K. Sorimachi, P. R. Larsen, and A. C. Bianco Human Type 3 Iodothyronine Selenodeiodinase Is Located in the Plasma Membrane and Undergoes Rapid Internalization to Endosomes J. Biol. Chem., January 3, 2003; 278(2): 1206 - 1211. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				B. Gereben, D. Salvatore, J. W. Harney, H. M. Tu, and P. R. Larsen The Human, but Not Rat, dio2 Gene Is Stimulated by Thyroid Transcription Factor-1 (TTF-1) Mol. Endocrinol., January 1, 2001; 15(1): 112 - 124. [Abstract] [Full Text]

				M. Murakami, O. Araki, T. Morimura, Y. Hosoi, H. Mizuma, M. Yamada, H. Kurihara, S. Ishiuchi, M. Tamura, T. Sasaki, et al. Expression of Type II Iodothyronine Deiodinase in Brain Tumors J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4403 - 4406. [Abstract] [Full Text]

				M. Eravci, G. Pinna, H. Meinhold, and A. Baumgartner Effects of Pharmacological and Nonpharmacological Treatments on Thyroid Hormone Metabolism and Concentrations in Rat Brain Endocrinology, March 1, 2000; 141(3): 1027 - 1040. [Abstract] [Full Text] [PDF]

				A. Campos-Barros, L. L. Amma, J. S. Faris, R. Shailam, M. W. Kelley, and D. Forrest Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing PNAS, February 1, 2000; 97(3): 1287 - 1292. [Abstract] [Full Text] [PDF]

				H. M. Tu, G. Legradi, T. Bartha, D. Salvatore, R. M. Lechan, and P. R. Larsen Regional Expression of the Type 3 Iodothyronine Deiodinase Messenger Ribonucleic Acid in the Rat Central Nervous System and Its Regulation by Thyroid Hormone Endocrinology, February 1, 1999; 140(2): 784 - 790. [Abstract] [Full Text]

				T. T. Nguyen, F. Chapa, and J. J. DiStefano III Direct Measurement of the Contributions of Type I and Type II 5'-Deiodinases to Whole Body Steady State 3,5,3'-Triiodothyronine Production from Thyroxine in the Rat Endocrinology, November 1, 1998; 139(11): 4626 - 4633. [Abstract] [Full Text] [PDF]

				K. Richard, R. Hume, E. Kaptein, J. P. Sanders, H. van Toor, W. W. de Herder, J. C. den Hollander, E. P. Krenning, and T. J. Visser Ontogeny of Iodothyronine Deiodinases in Human Liver J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2868 - 2874. [Abstract] [Full Text]

				S. Pallud, A.-M. Lennon, M. Ramauge, J.-M. Gavaret, W. Croteau, M. Pierre, F. Courtin, and D. L. St. Germain Expression of the Type II Iodothyronine Deiodinase in Cultured Rat Astrocytes Is Selenium-dependent J. Biol. Chem., July 18, 1997; 272(29): 18104 - 18110. [Abstract] [Full Text] [PDF]

				G. Pinna, H. Meinhold, L. Hiedra, R. Thoma, T. Hoell, K.-J. Graf, G. Stoltenburg-Didinger, M. Eravci, H. Prengel, O. Brodel, et al. Elevated 3,5-Diiodothyronine Concentrations in the Sera of Patients with Nonthyroidal Illnesses and Brain Tumors J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1535 - 1542. [Abstract] [Full Text] [PDF]